Leadership
BioAuraGen was founded by Che-Hung Yeh and Kay Tong, biotechnology executives with over 65 years of combined industry experience across pharmaceutical operations, business development, and strategic partnerships. Leveraging deep industry expertise and a global network of innovators, they focus on identifying and acquiring promising therapeutic assets with strong scientific and commercial potential. BioAuraGen was established to accelerate the development and commercialization of breakthrough innovations through strategic licensing and global partnerships.